OSL — Oncosil Medical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$22.24m
- AU$15.78m
- AU$1.82m
Annual cashflow statement for Oncosil Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.842 | 0.884 | 1.17 | 1.14 | 1.98 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.1 | -11.3 | -10.8 | -12.1 | -10.5 |
| Capital Expenditures | -0.006 | -0.058 | -0.197 | -0.015 | -0.001 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.006 | -0.058 | -0.197 | -0.015 | -0.001 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.16 | 9.49 | 6.13 | 12.7 | 11.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.96 | -1.89 | -4.89 | 0.608 | 1.37 |